Evaluation of Clinical Variables Affecting Myocardial Glucose Uptake in Cardiac FDG PET.

ABSTRACT:

Purpose

Cardiac 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography (FDG PET) is widely used to assess myocardial viability in patients with ischemic heart disease. While sufficient glucose uptake is a prerequisite for accurate interpretation of cardiac viability, there are a lack of data on which clinical variables have the most significant impact on myocardial glucose metabolism. Therefore, this study was designed to evaluate several clinical variables that could affect myocardial glucose metabolism.

Methods

A total of 214 consecutive cases were retrospectively enrolled in this study. All subjects received 250 mg of acipimox and underwent glucose loading as preparation for cardiac FDG PET/CT. Three-dimensional regions of interest (ROIs) were drawn on PET/CT fusio

SUBMITTER: Lee Y 

PROVIDER: S-EPMC11353438 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature